These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36855064)

  • 1. "There's absolutely no downside to this, I mean, except community opposition:" A qualitative study of the acceptability of vending machines for harm reduction.
    Stewart RE; Cardamone NC; Loscalzo E; French R; Lovelace C; Mowenn WK; Tarhini A; Lalley-Chareczko L; Brady KA; Mandell DS
    Harm Reduct J; 2023 Feb; 20(1):25. PubMed ID: 36855064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study.
    Safi F; Rioux W; Rider N; Fornssler B; Jones S; Ghosh SM
    Harm Reduct J; 2023 May; 20(1):64. PubMed ID: 37158926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative evaluation of digital vending machines to improve access to STI and HIV testing in South West England: using a Person-Based Approach.
    Gobin M; Horwood J; Stockwell S; Denford S; Copping J; Lawson L; Hayward S; Harryman L; Kesten JM
    BMJ Open; 2024 Jun; 14(6):e084786. PubMed ID: 38862218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of a trial of syringe vending machines in Canberra, Australia.
    McDonald D
    Int J Drug Policy; 2009 Jul; 20(4):336-9. PubMed ID: 18790622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.
    Boucher LM; Marshall Z; Martin A; Larose-Hébert K; Flynn JV; Lalonde C; Pineau D; Bigelow J; Rose T; Chase R; Boyd R; Tyndall M; Kendall C
    Harm Reduct J; 2017 May; 14(1):18. PubMed ID: 28494774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD.
    French R; Holliday Davis M; Aronowitz SV; Crowe M; Abrams M; Edwards G; Lowenstein M
    Addict Sci Clin Pract; 2023 Jun; 18(1):41. PubMed ID: 37355639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.
    Parry RA; Zule WA; Hurt CB; Evon DM; Rhea SK; Carpenter DM
    Harm Reduct J; 2021 Jul; 18(1):70. PubMed ID: 34238306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.
    Ghaddar A; Nassar K; Elsoury G
    Subst Use Misuse; 2017 Sep; 52(11):1420-1428. PubMed ID: 28430013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
    Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
    Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "We want everything in a one-stop shop": acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs.
    Bartholomew TS; Andraka-Cristou B; Totaram RK; Harris S; Doblecki-Lewis S; Ostrer L; Serota DP; Forrest DW; Chueng TA; Suarez E; Tookes HE
    Harm Reduct J; 2022 Dec; 19(1):133. PubMed ID: 36463183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staff perceptions of syringe dispensing machines in Australia: a pilot study.
    Islam MM; Conigrave KM; Stern T
    Subst Use Misuse; 2009; 44(4):490-501. PubMed ID: 19283622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico.
    Philbin MM; Mantsios A; Lozada R; Case P; Pollini RA; Alvelais J; Latkin CA; Magis-Rodriguez C; Strathdee SA
    Int J Drug Policy; 2009 Jul; 20(4):329-35. PubMed ID: 18963906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringe vending machines for injection drug users: an experiment in Marseille, France.
    Obadia Y; Feroni I; Perrin V; Vlahov D; Moatti JP
    Am J Public Health; 1999 Dec; 89(12):1852-4. PubMed ID: 10589315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study of the feasibility of pharmacy-delivered harm reduction services among people who inject drugs in Xichang, China.
    Yang Y; Latkin CA; Luan R; Yang C
    BMC Public Health; 2015 Sep; 15():885. PubMed ID: 26370245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and Staff Perspectives on the Impacts and Challenges of Hospital-Based Harm Reduction.
    Fraimow-Wong L; Martín M; Thomas L; Giuliano R; Nguyen OK; Knight K; Suen LW
    JAMA Netw Open; 2024 Feb; 7(2):e240229. PubMed ID: 38386317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-design of harm reduction materials for people who inject drugs to implement research findings.
    Hussey D; Trinder-Widdess Z; Dee C; Bagnall D; Bojangles T; Kesten JM
    Harm Reduct J; 2019 Jun; 16(1):36. PubMed ID: 31174536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "They accept me, because I was one of them": formative qualitative research supporting the feasibility of peer-led outreach for people who use drugs in Dakar, Senegal.
    Stengel CM; Mane F; Guise A; Pouye M; Sigrist M; Rhodes T
    Harm Reduct J; 2018 Feb; 15(1):9. PubMed ID: 29486774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.